ストックスクリーナーアプリを入手
0.74
8.95%
-0.0727
前日終値:
$0.8127
開ける：
$0.849
24時間の取引高:
89,909
Relative Volume:
0.27
時価総額：
$11.05M
収益：
当期純損益:
$-15.91M
株価収益率:
-0.5121
EPS:
-1.445
ネットキャッシュフロー:
$-15.07M
1週間 パフォーマンス:
-21.28%
1か月 パフォーマンス:
-56.73%
6か月 パフォーマンス:
-62.44%
1年 パフォーマンス:
-82.95%
1日の値動き範囲:
$0.74
$0.85
1週間の範囲:
$0.7603
$1.07
52週間の値動き範囲:
$0.74
$4.6891
Lantern Pharma Inc Stock (LTRN) Company Profile
Compare LTRN vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
0.74 | 11.05M | 0 | -15.91M | -15.07M | -1.445 |
VRTX
Vertex Pharmaceuticals Inc
|
511.62 | 129.68B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
224.95 | 89.81B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
764.98 | 78.76B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
817.37 | 51.40B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.91 | 40.49B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-07 | 開始されました | H.C. Wainwright | Buy |
Lantern Pharma Inc (LTRN) 最新ニュース
Lantern Pharma Schedules Virtual 2026 Annual Meeting with Seven Key Proposals on December 1 - Kalkine Media
With 281,597 shares unissued and unreserved, Lantern Pharma (LTRN) proposes a higher share limit. - Stock Titan
More than half of Taiwan’s lung cancer patients never smoked. A trial site there is screening patients. - Stock Titan
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance Australia
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance UK
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - BioSpace
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com South Africa
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com Canada
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com Nigeria
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com India
Lantern Pharma Raises $4.0 Million in Registered Direct; Issues Warrants, Engages Rodman & Renshaw - TradingView
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com UK
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - Business Wire
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com South Africa
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com Nigeria
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com Canada
Lantern Pharma raises $4M in registered direct offering - Investing.com
Lantern Pharma announces up to $8M registered direct offering - TradingView
Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering - Business Wire
Lantern Pharma Inc. (LTRN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com Nigeria
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com India
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com UK
Form 8K Lantern Pharma Inc For: 23 September By Investing.com - Investing.com Nigeria
Form 8K Lantern Pharma Inc For: 23 September By Investing.com - Investing.com UK
A cancer drug could gain patent protection through 2042. Lantern Pharma’s LP-284 targets two blood cancers. - Stock Titan
Lantern Pharma Inc (NASDAQ: LTRN) Share Price, LTRN Stock News, LTRN Share Price & Updates - kalkine.ca
Lantern Pharma Q2 2026 Earnings Call: Complete Transcript - benzinga.com
Lantern Pharma Share PriceLTRN, RNS News, Articles, Quotes, & Charts (NASDAQ:LTRN) - Proactive financial news
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - guardonline.com
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - 富途牛牛
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - Yahoo Finance
Lantern Pharma Inc. (LTRN) Stock Price & News - Syfe
Lantern Pharma Earnings Call: AI Spinout, Trial Momentum - TipRanks
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript - AOL.com
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Here's Why We're A Bit Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation - Sahm
Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI - GuruFocus
Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI-Driven Pipeline Advances Amid ... - Yahoo Finance
Lantern Pharma Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Lantern Pharma Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:LTRN) 2026-08-17 - Seeking Alpha
Lantern Pharma (LTRN) Slides 2.26% as Biotech Stock Approaches Critical $2.46 SupportKey Reversal Day - vinanet.vn
Lantern Pharma (LTRN) Updates Trial Design Amid Cash Raise; Mark - GuruFocus
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceBull Pennant - vinanet.vn
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceFRAMA Signal - dars.gov.et
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceVolume Profile - careplusvn.com
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceCall Flow Alert - dars.gov.et
Form 8K Lantern Pharma Inc For: 14 August By Investing.com - Investing.com Nigeria
LTRN: Static price chart | Lantern Pharma Inc. | US51654W1018 - marketscreener.com
Lantern Pharma Releases Q2 2026 Financial Results - AlphaStreet
Lantern Pharma Inc (LTRN) 財務データ
収益
当期純利益
現金流量
EPS
Lantern Pharma Inc (LTRN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| KEYSER D JEFFREY | Director |
May 12 '26 |
Buy |
2.06 |
48,544 |
100,001 |
94,303 |
5.61%
0.92%
大文字化:
|
ボリューム (24 時間):